Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying the stock. We monitor 13F filings and institutional buying patterns because large investors often have superior information.
As of 2026-04-13, Omnicell Inc. (OMCL), a provider of pharmacy and clinical workflow automation solutions for healthcare facilities, is trading at $34.99, marking a 1.72% gain on the day. This analysis evaluates recent price action, sector context, and key technical levels for the stock, as investors weigh broader market trends against company-specific dynamics. No recent earnings data is available for OMCL as of this writing, so recent price moves have been driven primarily by sector flows and
Is Omnicell (OMCL) Stock Trending Down | Price at $34.99, Up 1.72% - Portfolio Ideas
OMCL - Stock Analysis
4237 Comments
1702 Likes
1
Leilannie
Daily Reader
2 hours ago
Free US stock put/call ratio analysis and sentiment contrarian indicators for market timing signals and sentiment assessment. We monitor options market activity to understand when markets might be too bullish or bearish and due for a reversal. We provide put/call ratio analysis, sentiment contrarian signals, and market timing indicators for comprehensive coverage. Time the market with our comprehensive sentiment analysis and contrarian indicators tools for contrarian investing.
π 167
Reply
2
Tamer
Regular Reader
5 hours ago
Mixed sentiment across sectors is creating a balanced market environment.
π 244
Reply
3
Aaraf
New Visitor
1 day ago
This gave me a sense of control I donβt have.
π 166
Reply
4
Valik
New Visitor
1 day ago
This feels like a strange alignment.
π 102
Reply
5
Tremonte
Trusted Reader
2 days ago
If only I had spotted this sooner.
π 261
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.